Drug intelligence / Profile preview

arginine + canola oil

Development stage
Unknown
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Oral
01

Overview

Arginine + canola oil is a combination of the semi-essential amino acid arginine and the edible vegetable oil derived from rapeseed (canola). This combination has been studied primarily as an immunonutritional supplement, especially in clinical settings such as kidney transplant recipients and critically ill or injured patients. Arginine serves as a precursor for nitric oxide synthesis, which plays a key role in vasodilation, immune modulation, and wound healing. Canola oil provides essential fatty acids (mainly monounsaturated fats) that may have anti-inflammatory properties. Clinical studies suggest that supplementation with oral arginine (typically 9–30 g/day) combined with canola oil (about 30 mL/day) is safe and may reduce complications such as organ rejection, infection, new-onset diabetes, and cardiovascular disease after kidney transplantation. The mechanism of action involves enhancement of immune function through improved leukocyte activity and modulation of inflammatory responses[1][3][8]. This combination is not an approved pharmaceutical drug but rather used as part of specialized nutritional support protocols.

Other names
arginine and canola oilL-arginine + canola oil
02

Targets

NOS1 (nNOS)Cholesterol

Beyond the preview

Go deeper on arginine + canola oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on arginine + canola oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call